Because LRP is a protein encoded by MVP, which interacts with YPEL4, targeting YPEL4 may affect the interaction with LRP and pose as a potential treatment for non-small- cell lung cancer where LRP expression is higher. The gene discussed is YPEL4; the disease is non-small cell lung carcinoma.